BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33579803)

  • 1. Improved Primary Staging of Marginal-Zone Lymphoma by Addition of CXCR4-Directed PET/CT.
    Duell J; Krummenast F; Schirbel A; Klassen P; Samnick S; Rauert-Wunderlich H; Rasche L; Buck AK; Wester HJ; Rosenwald A; Einsele H; Topp MS; Lapa C; Kircher M
    J Nucl Med; 2021 Oct; 62(10):1415-1421. PubMed ID: 33579803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [
    Kosmala A; Duell J; Schneid S; Serfling SE; Higuchi T; Weich A; Lapa C; Hartrampf PE; Raderer M; Einsele H; Buck AK; Topp MS; Schlötelburg W; Werner RA
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):749-755. PubMed ID: 37943339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma.
    Duell J; Buck AK; Hartrampf PE; Schlötelburg W; Schneid S; Weich A; Dreher N; Lapa C; Kircher M; Higuchi T; Samnick S; Serfling SE; Raderer M; Rasche L; Einsele H; Topp MS; Kosmala A; Werner RA
    J Nucl Med; 2023 Dec; 64(12):1889-1894. PubMed ID: 37797975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging Inflammation in Atherosclerosis with CXCR4-Directed
    Kircher M; Tran-Gia J; Kemmer L; Zhang X; Schirbel A; Werner RA; Buck AK; Wester HJ; Hacker M; Lapa C; Li X
    J Nucl Med; 2020 May; 61(5):751-756. PubMed ID: 31653710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR4-Directed PET/CT with [
    Chen Z; Yang A; Zhang J; Chen A; Zhang Y; Huang C; Chen S; Yao S; Miao W
    Mol Imaging Biol; 2022 Jun; 24(3):416-424. PubMed ID: 34651291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [
    Lapa C; Schreder M; Schirbel A; Samnick S; Kortüm KM; Herrmann K; Kropf S; Einsele H; Buck AK; Wester HJ; Knop S; Lückerath K
    Theranostics; 2017; 7(1):205-212. PubMed ID: 28042328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma.
    Hoffmann M; Kletter K; Becherer A; Jäger U; Chott A; Raderer M
    Oncology; 2003; 64(4):336-40. PubMed ID: 12759529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer - a first clinical approach.
    Linde P; Baues C; Wegen S; Trommer M; Quaas A; Rosenbrock J; Celik E; Marnitz S; Bruns CJ; Fischer T; Schomaecker K; Wester HJ; Drzezga A; van Heek L; Kobe C
    Cancer Imaging; 2021 Feb; 21(1):22. PubMed ID: 33579381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients.
    Bluemel C; Hahner S; Heinze B; Fassnacht M; Kroiss M; Bley TA; Wester HJ; Kropf S; Lapa C; Schirbel A; Buck AK; Herrmann K
    Clin Nucl Med; 2017 Jan; 42(1):e29-e34. PubMed ID: 27819856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of [
    Albano D; Dondi F; Bertagna F; Treglia G
    Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoma-Sink Effect in Marginal Zone Lymphoma Based on CXCR4-Targeted Molecular Imaging.
    Kosmala A; Seifert S; Schneid S; Dreher N; Higuchi T; Weich A; Serfling SE; Hartrampf PE; Einsele H; Buck AK; Topp MS; Duell J; Werner RA
    Mol Imaging Biol; 2023 Aug; 25(4):758-764. PubMed ID: 37286923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of CXCR4-Directed PET/CT on Staging and Proposed Oncologic Management in Patients With Digestive System Tumors.
    Weich A; Serfling SE; Schlötelburg W; Higuchi T; Hartrampf PE; Schirbel A; Heinrich M; Buck AK; Rowe SP; Kosmala A; Werner RA
    Clin Nucl Med; 2023 Jul; 48(7):586-593. PubMed ID: 37167408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas.
    Karam M; Novak L; Cyriac J; Ali A; Nazeer T; Nugent F
    Cancer; 2006 Jul; 107(1):175-83. PubMed ID: 16721817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and pathological predictors for FDG-PET/CT avidity in patients with marginal zone lymphoma-a retrospective cohort study.
    Kagan KBT; Guz D; Buchrits S; Gurion R; Vaxman I; Priss M; Groshar D; Catalano OA; Sherban A; Raanani P; Gafter-Gvili A; Bernstine H
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2290-2299. PubMed ID: 35079846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response assessment with the CXCR4-directed positron emission tomography tracer [
    Herhaus P; Habringer S; Vag T; Steiger K; Slotta-Huspenina J; Gerngroß C; Wiestler B; Wester HJ; Schwaiger M; Keller U
    EJNMMI Res; 2017 Dec; 7(1):51. PubMed ID: 28577295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas.
    Weich A; Werner RA; Buck AK; Hartrampf PE; Serfling SE; Scheurlen M; Wester HJ; Meining A; Kircher S; Higuchi T; Pomper MG; Rowe SP; Lapa C; Kircher M
    Diagnostics (Basel); 2021 Mar; 11(4):. PubMed ID: 33805264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative Approach.
    Werner RA; Weich A; Higuchi T; Schmid JS; Schirbel A; Lassmann M; Wild V; Rudelius M; Kudlich T; Herrmann K; Scheurlen M; Buck AK; Kropf S; Wester HJ; Lapa C
    Theranostics; 2017; 7(6):1489-1498. PubMed ID: 28529632
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Luo Y; Cao X; Pan Q; Li J; Feng J; Li F
    J Nucl Med; 2019 Dec; 60(12):1724-1729. PubMed ID: 31101745
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of 18F-FDG-PET/CT in the management of marginal zone B cell lymphoma.
    Carrillo-Cruz E; Marín-Oyaga VA; de la Cruz Vicente F; Borrego-Dorado I; Ruiz Mercado M; Acevedo Báñez I; Solé Rodríguez M; Fernández López R; Pérez Vega H; Calderón-Cabrera C; Espigado Tocino I; Pérez-Simón JA; Vázquez-Albertino R
    Hematol Oncol; 2015 Dec; 33(4):151-8. PubMed ID: 25407794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [
    Pan Q; Luo Y; Zhang Y; Chang L; Li J; Cao X; Li J; Li F
    EJNMMI Res; 2020 Aug; 10(1):89. PubMed ID: 32757068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.